Low-dose valaciclovir prophylaxis against cytomegalovirus disease in renal transplant recipients.
High-dose valaciclovir at up to 8 g/day has been shown to be effective in prophylaxis against cytomegalovirus (CMV) disease in renal transplant recipients. We report our experience with low-dose valaciclovir prophylaxis of up to 3 g/day, adjusted to creatinine clearance. A group of patients at high...
Автори: | Reddy, S, Handa, A, Tan, L, Devaney, A, Hughes, D, Mason, P, Friend, P, Darby, C |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
2003
|
Схожі ресурси
Схожі ресурси
-
Comparison between valganciclovir and aciclovir/valaciclovir for CMV prophylaxis in pediatric renal transplantation
за авторством: M Fila, та інші
Опубліковано: (2015-01-01) -
Prophylaxis of Cytomegalovirus in Renal Transplant Recipients
за авторством: Allan S MacDonald, та інші
Опубліковано: (1993-01-01) -
Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients.
за авторством: Hughes, D, та інші
Опубліковано: (2008) -
Resistant cytomegalovirus infection in renal transplant recipients
за авторством: Benjamin Pei Zhi Cherng, та інші
Опубліковано: (2015-12-01) -
Tuberculosis in Renal Transplant Recipients: The Evidence for Prophylaxis
за авторством: Currie, A, та інші
Опубліковано: (2010)